What is the recommended antiviral treatment for hand, foot, and mouth disease?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 14, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Hand, Foot, and Mouth Disease: No Antiviral Treatment Recommended

There is no approved or recommended antiviral treatment for hand, foot, and mouth disease—management is entirely supportive with pain control and hydration. 1, 2

Why No Antiviral Therapy?

The evidence is clear and consistent across all guidelines:

  • No antiviral agents are currently approved for treating HFMD, despite the disease being caused by enteroviruses (primarily coxsackievirus A16 and enterovirus A71) 2
  • While experimental drugs like ribavirin, suramin, mulberroside C, aminothiazole analogs, and sertraline have emerged as potential candidates in research settings, none are approved for clinical use 3
  • The disease is self-limited in the vast majority of cases, resolving in 7-10 days without sequelae, making antiviral development less of a priority 2, 3

Recommended Treatment Approach

For Mild Cases (>95% of patients)

Symptomatic management only:

  • Oral analgesics: Acetaminophen or NSAIDs for limited duration to relieve pain and reduce fever 1
  • Hydration support: Critical given painful oral lesions may reduce oral intake 1
  • Oral care: Mild toothpaste and gentle oral hygiene 1
  • Avoid oral lidocaine: Not recommended despite common use 2

For Severe Cases with Neurological Complications

Escalate to immunomodulatory therapy:

  • Intravenous immunoglobulin (IVIG) should be considered for severe/complicated HFMD and is recommended by several national and international guideline committees 3
  • Glucocorticoid therapy is commonly used alongside IVIG for neurological complications 4
  • These interventions are reserved for patients with meningoencephalitis, brainstem encephalitis, or other severe neurological manifestations (primarily EV-A71 cases) 4, 5

Critical Warning Signs Requiring Escalation

Watch for these indicators of deterioration that warrant intensive treatment (not antivirals, but IVIG/steroids):

  • Persistent hyperthermia despite antipyretics 5
  • Nervous system involvement (myoclonic jerks, seizures, altered consciousness) 4, 5
  • Worsening respiratory rate and rhythm 5
  • Circulatory dysfunction 5
  • Elevated peripheral WBC count, blood glucose, or lactic acid 5

Children under 3 years with EV-A71 infection and disease duration less than 3 days are highest risk 5

Common Pitfalls to Avoid

  • Do not prescribe oral lidocaine for oral pain—it is specifically not recommended despite intuitive appeal 2
  • Do not use topical antivirals (like acyclovir)—HFMD is not caused by herpes viruses 1
  • Do not delay recognition of severe cases waiting for antiviral options that don't exist—early IVIG/steroid intervention for neurological complications is what saves lives 4, 3
  • Do not confuse this with herpes simplex virus which does have antiviral treatment options 6

The mortality in severe HFMD comes from circulatory failure secondary to myocardial impairment and neurogenic pulmonary edema from brainstem damage—not from lack of antivirals, but from delayed recognition and supportive/immunomodulatory intervention 3

References

Guideline

Diagnosis and Management of Hand, Foot, and Mouth Disease

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Hand-Foot-and-Mouth Disease: Rapid Evidence Review.

American family physician, 2019

Research

Hand, Foot, and Mouth Disease: A Narrative Review.

Recent advances in inflammation & allergy drug discovery, 2022

Research

Neurological Complications Of Hand, Foot And Mouth Disease In Children: A Review.

Journal of Ayub Medical College, Abbottabad : JAMC, 2020

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.